W.R. Berkley Corp’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-173,530
Closed -$1.74M – 197
2024
Q4
$1.74M Buy
+173,530
New +$1.74M 0.07% 110

Other funds holding TDACU

W.R. Berkley Corp's TDACU Position: Q1 2025 in Review

W.R. Berkley Corp sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 173,530 shares — an estimated $1.74M sold.

W.R. Berkley Corp first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $1.74M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • W.R. Berkley Corp reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • W.R. Berkley Corp sold 173,530 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $1.74M.
  • W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • W.R. Berkley Corp's Translational Development Acquisition Corp Units position peaked at $1.74M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on W.R. Berkley Corp's 13F filing for Q1 2025, filed 15 May 2025.